 |
| Diana Scott |
Finn Partners has added Diana Scott, who most recently was senior VP at Porter Novelli in her more than 20-year healthcare PR career, as partner in its health unit.
She has extensive experience in oncology, cardiometabolic disease categories and has promoted pharmaceutical portfolios, product launches, global data communications campaigns and handled regulatory support.
"Content drives communications across all medium and Finn has an obligation to clients championing the cancer, cardiovascular, mental health and rare disease categories to be a strong partner ensuring our efforts lead to life-improving action," Gil Bashe, managing partner of Finn's global health practice, told O'Dwyer's. "Hiring Diana Scott, with her clinical expertise and proven ability to mobilize communities, responds to that client environment.”
Scott, who also held top jobs in the healthcare units of Weber Shandwick and Ruder Finn, reports to Kristie Kuhl, managing partner of Finn Partners' New York and Chicago health teams and head of the US pharma group.
Finn Partners ranked No. 6 in O'Dwyer's 2018 healthcare rankings with fees of $21.2M.
To negotiate the demands of media, investors, regulators and the market, communicators to make sure that their narrative they construct is defensible every stop of the way.
In a health landscape crowded with claims, brands earn trust by pairing credible proof with human stories, cultural relevance, and empowerment.
Binaytara, the Bellevue, WA-based nonprofit dedicated to improving access to cancer care and fostering scientific research, has appointed FINN Partners as its global PR firm.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
